Bipartisan Bill Seeks to Make US Pharmaceutical Supply Chain Less Dependent on Foreign Countries Like China

An employee at Capitol Carbonic, which makes dry ice used by the pharmaceutical industry, uses a forklift to move a cooler of dry ice pellets in a warehouse in Baltimore, Maryland, on Nov. 20, 2020. Saul Loeb/AFP/Getty Images

A bipartisan group of lawmakers on June 16 reintroduced legislation that would make the U.S. pharmaceutical supply chain less dependent on foreign countries such as China.

The measure seeks to help mitigate shortages while incentivizing the domestic production of drugs, active pharmaceutical ingredients, personal protective equipment (PPE), and diagnostics, according to Rep. Earl L. “Buddy” Carter (R-Ga.), one of the bill’s co-sponsors.